SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
11-Aug-20 5:08 PM View: | Ibio, Inc. (IBIO) | 11-Aug-20 | Market Sale | 15,864,400 | $2.92 | $46,330,500.00 | (65%) 24.49M to 8.63M | 60% |
11-Aug-20 5:08 PM View: | Ibio, Inc. (IBIO) | 10-Aug-20 | Market Sale | 7,264,860 | $3.91 | $28,429,600.00 | (23%) 31.76M to 24.49M | 70% |
11-Aug-20 5:08 PM View: | Ibio, Inc. (IBIO) | 07-Aug-20 | Conversion | 28,925,000 | $0.20 | $5,785,000.00 | 690% 4.19M to 33.11M | |
11-Aug-20 5:08 PM View: | Ibio, Inc. (IBIO) | 07-Aug-20 | Market Sale | 1,355,600 | $3.83 | $5,185,590.00 | (4%) 33.11M to 31.76M | 70% |
06-Aug-20 5:33 PM View: | Ibio, Inc. (IBIO) | 06-Aug-20 | Market Sale | 2,768,140 | $4.18 | $11,570,500.00 | (8%) 35.88M to 33.11M | 72% |
06-Aug-20 5:33 PM View: | Ibio, Inc. (IBIO) | 05-Aug-20 | Market Sale | 900,000 | $4.46 | $4,013,550.00 | (2%) 36.78M to 35.88M | 74% |
06-Aug-20 5:33 PM View: | Ibio, Inc. (IBIO) | 04-Aug-20 | Market Sale | 600,000 | $4.39 | $2,636,640.00 | (2%) 37.38M to 36.78M | 74% |
20-Feb-20 4:50 PM View: | Marker Therapeutics, Inc. (MRKR) | 18-Feb-20 | Exercise (in-the money or at-the-money) | 416,667 | $1.20 | $500,000.00 | 11% 3.63M to 4.05M | |
13-Jul-18 4:06 PM View: | Ibio, Inc. (IBIO) | 12-Jul-18 | Market Purchase | 2,200,000 | $0.90 | $1,980,000.00 | 35% 6.26M to 8.46M | 16% |
28-Jun-18 6:03 PM View: | Ibio, Inc. (IBIO) | 26-Jun-18 | Market Purchase | 1,683,330 | $0.90 | $1,515,000.00 | 37% 4.57M to 6.26M | 14% |
16-May-18 5:28 PM View: | Marker Therapeutics, Inc. (MRKR) | 14-May-18 | Private Purchase | 1,300,000 | $2.40 | $3,120,000.00 | 32% 4.0M to 5.3M | |
04-Dec-17 5:14 PM View: | Ibio, Inc. (IBIO) | 30-Nov-17 | Market Purchase | 12,000,000 | $0.20 | $2,400,000.00 | 36% 33.74M to 45.74M | (53%) |
21-Jul-17 5:37 PM View: | Cyclacel Pharmaceuticals, I... (CYCC) | 19-Jul-17 | Purchase | 850,000 | $2.00 | $1,700,000.00 | 65% 1.32M to 2.17M | |
12-Aug-16 4:40 PM View: | Marker Therapeutics, Inc. (MRKR) | 10-Aug-16 | Acquisition (other) | 3,000,000 | -- | -- | 15% 20.0M to 23.0M | |
12-Aug-16 4:40 PM View: | Marker Therapeutics, Inc. (MRKR) | 10-Aug-16 | Exercise (in-the money or at-the-money) | 5,000,000 | $0.50 | $2,500,000.00 | 22% 23.0M to 28.0M | (100%) |
11-Apr-16 2:58 PM View: | Ibio, Inc. (IBIO) | 07-Apr-16 | Market Purchase | 6,500,000 | $0.62 | $4,043,000.00 | 24% 27.24M to 33.74M | (87%) |
27-Jan-16 12:12 PM View: | Ibio, Inc. (IBIO) | 25-Jan-16 | Market Purchase | 3,500,000 | $0.62 | $2,177,000.00 | 16% 21.96M to 25.46M | (87%) |
27-Jan-16 12:12 PM View: | Ibio, Inc. (IBIO) | 25-Jan-16 | Exercise (in-the money or at-the-money) | 1,784,000 | $0.53 | $945,520.00 | 7% 25.46M to 27.24M | (84%) |
11-Sep-15 4:16 PM View: | Marker Therapeutics, Inc. (MRKR) | 09-Sep-15 | Exercise (in-the money or at-the-money) | 10,000,000 | $0.20 | $2,000,000.00 | 100% 10.0M to 20.0M | |
18-Jun-15 11:33 AM View: | Marker Therapeutics, Inc. (MRKR) | 16-Jun-15 | Exercise (in-the money or at-the-money) | 5,000,000 | $0.50 | $2,500,000.00 | 100% 5.0M to 10.0M | |
11-Jul-14 9:55 PM View: | Aastrom Biosciences, Inc. (VCEL) | 09-Jul-14 | Exercise (out-of-the-money) | 362,500 | $4.80 | $1,740,000.00 | 85% 424.99K to 787.49K | |
27-Feb-14 3:33 PM View: | Cytokinetics Inc. (CYTK) | 25-Feb-14 | Private Purchase | 500,000 | $8.00 | $4,000,000.00 | 21% 2.38M to 2.88M | |
30-Apr-13 3:37 PM View: | Ibio, Inc. (IBIO) | 26-Apr-13 | Purchase | 4,460,000 | -- | -- | 45% 10.0M to 14.46M |